The China National Intellectual Property Administration (CNIPA) on November 25 announced the change in the currency of fees payable to the CNIPA of international applications filed under the Patent Cooperation Treaty (PCT).
Evidence is crucial to IP infringement litigation. For a long time, no strong evidence discovery mechanism had been established in China’s law court system. But things are improving.
The China National Intellectual Property Administration (CNIPA) on November 16 issued the second amendment of the Measures for the Registration of Pledge of Patent Rights (《专利权质押登记办法》), which became effective in 2010.
The Boards of Appeal of the European Patent Office have upheld a decision revoking an important technology patent
Japan's Chugai Pharmaceutical Co., Ltd. has recently filed a patent infringement lawsuit in the Beijing Intellectual Property Court against Chinese rival Haihe Pharmaceutical Industry, seeking to stay the marketing approval process for its generic drug Eldecalcitol.
